Astrazeneca Regulatory News (AZN)

Resolution

Votes for

% of votes cast

Votes against

% of votes cast

Votes cast in total

Total votes cast as a % of issued share capital

Votes withheld

1

To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2022

1,264,644,490

99.80

2,524,193

0.20

1,267,168,683

81.76

2,068,894

2

To confirm dividends

1,254,919,878

98.92

13,679,112

1.08

1,268,598,990

81.85

638,576

3

To reappoint PricewaterhouseCoopers LLP as Auditor

1,260,792,714

99.39

7,718,080

0.61

1,268,510,794

81.85

726,500

4

To authorise the Directors to agree the remuneration of the Auditor

1,268,225,831

99.98

270,095

0.02

1,268,495,926

81.85

741,641

5a

To re-elect Michel Demaré as a Director

1,241,496,328

97.88

26,829,809

2.12

1,268,326,137

81.84

911,430

5b

To re-elect Pascal Soriot as a Director

1,260,336,535

99.37

7,986,485

0.63

1,268,323,020

81.83

914,729

5c

To re-elect Aradhana Sarin as a Director

1,265,264,711

99.76

3,062,442

0.24

1,268,327,153

81.84

910,131

5d

To re-elect Philip Broadley as a Director

1,259,273,602

99.29

9,043,851

0.71

1,268,317,453

81.83

920,114

5e

To re-elect Euan Ashley as a Director

1,268,022,043

99.98

282,266

0.02

1,268,304,309

81.83

924,629

5f

To re-elect Deborah DiSanzo as a Director

1,267,959,577

99.97

349,778

0.03

1,268,309,355

81.83

926,746

5g

To re-elect Diana Layfield as a Director

1,268,027,536

99.98

274,653

0.02

1,268,302,189

81.83

935,378

5h

To re-elect Sheri McCoy as a Director

1,241,492,257

97.88

26,842,094

2.12

1,268,334,351

81.84

903,216

5i

To re-elect Tony Mok as a Director

1,261,574,735

99.97

322,367

0.03

1,261,897,102

81.42

7,338,922

5j

To re-elect Nazneen Rahman as a Director

1,266,284,904

99.85

1,870,104

0.15

1,268,155,008

81.82

1,082,559

5k

To re-elect Andreas Rummelt as a Director

1,268,030,928

99.98

285,793

0.02

1,268,316,721

81.83

920,846

5l

To re-elect Marcus Wallenberg as a Director

1,026,140,887

80.93

241,825,345

19.07

1,267,966,232

81.81

1,263,367

6

To approve the Annual Report on Remuneration for the year ended 31 December 2022

1,195,261,107

94.23

73,125,360

5.77

1,268,386,467

81.84

850,827

7

To authorise limited political donations

1,228,047,446

97.76

28,189,687

2.24

1,256,237,133

81.06

13,000,783

8

To authorise the Directors to allot shares

1,166,174,071

91.95

102,088,563

8.05

1,268,262,634

81.83

966,964

9

To authorise the Directors to disapply pre-emption rights

1,193,686,193

94.15

74,121,064

5.85

1,267,807,257

81.80

1,430,310

10

To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments

1,153,850,923

91.25

110,689,108

8.75

1,264,540,031

81.59

4,697,303

11

To authorise the Company to purchase its own shares

1,254,158,039

98.92

13,730,760

1.08

1,267,888,799

81.81

1,348,767

12

To reduce the notice period for general meetings

1,178,311,157

93.41

83,098,807

6.59

1,261,409,964

81.39

7,827,602

13

To adopt new Articles of Association of the Company

1,258,637,857

99.26

9,327,063

0.74

1,267,964,920

81.81

1,272,646